Fig. 11.
Events in patient OT 469, whose biopsy-proved rejection was reversed with OKT3 therapy. Treatment was started on the 6th postoperative day. Note the persistence of T3-positive lymphocytes in the circulation and T3 modulation during OKT3 therapy as well as the lymphocyte rebound after discontinuance of therapy. CyA = Ciclosporin. GOT = glutamic oxaloacetic transaminase; GPT = glutamic pyruvate transaminase.